Section
This RCT demonstrates that combining multidimensional functional training with inspiratory muscle training and chest physiotherapy improves weaning success, muscle strength, functional independence, pain reduction, and ICU stay following em
A deep learning model classifying usual interstitial pneumonia patterns on CT scans predicts fibrosis progression and mortality in individuals with interstitial lung abnormalities, offering a promising tool for risk stratification and clini
This review synthesizes evidence supporting outpatient management of acute low-risk pulmonary embolism (PE), highlighting risk stratification tools, safety outcomes, and implementation strategies to enhance adoption in clinical practice.
Quantitative CT imaging offers valuable prognostic information and helps assess treatment response in patients with progressive pulmonary fibrosis, supporting better clinical trial outcomes and therapeutic decisions.
This study explores how physical activity influences lung and kidney function in COVID-19 survivors, showing active survivors had better lung outcomes but no significant kidney benefits, highlighting the importance of tailored rehabilitatio
This review critically examines the SAVE-ICU trial assessing isoflurane inhaled sedation versus intravenous sedation in mechanically ventilated adults with acute hypoxemic respiratory failure, highlighting implications for clinical practice
Prioritized lung transplant recipients exhibit higher severe PGD rates and mortality, yet prioritization itself is not an independent PGD predictor; pre-transplant ECMO is the primary risk factor.
This review synthesizes current evidence on high-frequency chest wall oscillation (HFCWO) for airway clearance in acute respiratory failure with bronchial hypersecretion, highlighting recent RCT findings, mechanistic insights, and future re
This case series examines immunosuppressive management and long-term outcomes in nine Japanese patients undergoing single living-donor lobar lung transplantation from the same donor as prior HSCT, revealing viable reduced immunosuppression
This review synthesizes current evidence on pulse versus nonpulse corticosteroid therapy in AE-IPF, contextualizing the SAFER trial findings within prior studies and clinical guidelines to guide management and future research.
This review synthesizes evidence on the feasibility, acceptance, and clinical outcomes of pulmonary telerehabilitation models in COPD, highlighting technical reliability, patient adherence, and clinical benefits from recent trials, includin
In children with medical complexity hospitalized for nonsevere community-acquired pneumonia, broad-spectrum antibiotics show no advantage over narrow-spectrum agents, supporting targeted aminopenicillin use to improve outcomes and antibioti
The ENCORE trial demonstrates that amikacin liposome inhalation suspension combined with multidrug therapy improves respiratory symptoms and culture conversion in newly diagnosed Mycobacterium avium complex lung disease patients.
Baseline lung allograft dysfunction (BLAD) affects over 60% of bilateral lung transplant recipients, associates with increased mortality, and influences long-term lung function trajectories. Risk factors include higher BMI, prolonged ICU st
Rare coding variants in the FOXF1 gene are linked to pulmonary arterial hypertension (PAH), implicating impaired endothelial FOXF1 expression and disrupted BMPR2 regulation in disease development.
This study validates the Patient Dignity Inventory (PDI) as a reliable tool to assess dignity-related distress over 12 months in acute respiratory failure survivors, supporting dignity-centered interventions to improve long-term psychosocia
A concise, practice-focused summary of the 2026 GINA Strategy Report, highlighting new recommendations on inhaled corticosteroid–formoterol (AIR) strategies, severe asthma biologic guidance, and acute care updates.
Ondansetron, a 5-HT3 antagonist, reduces respiratory drive in ARDS patients on mechanical ventilation by attenuating pulmonary C-fiber mediated stimulation, potentially lessening lung injury and improving oxygenation.
A large UK study reveals that over two-thirds of biologic-eligible severe asthma patients improve without biologic therapy, identifying distinct exacerbation trajectories linked to blood eosinophil levels and disease phenotype.
An expert consensus from the BPD Collaborative outlines pragmatic, lifespan-focused recommendations to identify, monitor, and manage prematurity-associated lung disease (PLD) and to standardize outpatient care from infancy through adulthood
